Bio of David Whittlinger, former Intel health standards director, now NYeC executiveNew Leaf Funds performance summary (NLV-I & NLV-II) with capital commitments and IRR metrics
Case Filekaggle-ho-024029House OversightFund Performance Summary for New Leaf Healthcare Technology Venture Funds
Unknown1p4 persons
Case File
kaggle-ho-024029House OversightFund Performance Summary for New Leaf Healthcare Technology Venture Funds
Fund Performance Summary for New Leaf Healthcare Technology Venture Funds The document only provides historical investment performance metrics for a venture capital team, with no mention of political figures, government agencies, financial misconduct, or controversial actions. It lacks actionable leads or sensitive information. Key insights: Over $1.6 billion invested in healthcare tech since 1995.; Reported IRRs outpacing major public market indices.; Gross realizations exceed $2.6 billion across 126 companies.
Date
Unknown
Source
House Oversight
Reference
kaggle-ho-024029
Pages
1
Persons
4
Integrity
No Hash Available
Loading document viewer...
Forum Discussions
Advertisement
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, donor-supported, and independent. Donors see no ads.
Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.